Global Angiogenesis Modulators Market Insights and Forecast to 2031

Report ID: 1564655 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Angiogenesis Modulators Product Introduction
    1.2 Market by Type
        1.2.1 Global Angiogenesis Modulators Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Angiogenesis Inhibitors
        1.2.3 Angiogenesis Stimulators
        1.2.4 Angiogenin
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Angiogenesis Modulators Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Breast Cancer
        1.3.3 Colorectal Cancer
        1.3.4 Lung Cancer
        1.3.5 Prostate Cancer
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Angiogenesis Modulators Sales Estimates and Forecasts 2017-2028
    2.2 Global Angiogenesis Modulators Revenue Estimates and Forecasts 2017-2028
    2.3 Global Angiogenesis Modulators Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Angiogenesis Modulators Sales by Region
        2.4.1 Global Angiogenesis Modulators Sales by Region (2017-2022)
        2.4.2 Global Sales Angiogenesis Modulators by Region (2023-2028)
    2.5 Global Angiogenesis Modulators Revenue by Region
        2.5.1 Global Angiogenesis Modulators Revenue by Region (2017-2022)
        2.5.2 Global Angiogenesis Modulators Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Angiogenesis Modulators Sales by Manufacturers
        3.1.1 Global Top Angiogenesis Modulators Manufacturers by Sales (2017-2022)
        3.1.2 Global Angiogenesis Modulators Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Angiogenesis Modulators in 2021
    3.2 Global Angiogenesis Modulators Revenue by Manufacturers
        3.2.1 Global Angiogenesis Modulators Revenue by Manufacturers (2017-2022)
        3.2.2 Global Angiogenesis Modulators Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Angiogenesis Modulators Revenue in 2021
    3.3 Global Angiogenesis Modulators Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Angiogenesis Modulators Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Angiogenesis Modulators Sales by Type
        4.1.1 Global Angiogenesis Modulators Historical Sales by Type (2017-2022)
        4.1.2 Global Angiogenesis Modulators Forecasted Sales by Type (2023-2028)
        4.1.3 Global Angiogenesis Modulators Sales Market Share by Type (2017-2028)
    4.2 Global Angiogenesis Modulators Revenue by Type
        4.2.1 Global Angiogenesis Modulators Historical Revenue by Type (2017-2022)
        4.2.2 Global Angiogenesis Modulators Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Angiogenesis Modulators Revenue Market Share by Type (2017-2028)
    4.3 Global Angiogenesis Modulators Price by Type
        4.3.1 Global Angiogenesis Modulators Price by Type (2017-2022)
        4.3.2 Global Angiogenesis Modulators Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Angiogenesis Modulators Sales by Application
        5.1.1 Global Angiogenesis Modulators Historical Sales by Application (2017-2022)
        5.1.2 Global Angiogenesis Modulators Forecasted Sales by Application (2023-2028)
        5.1.3 Global Angiogenesis Modulators Sales Market Share by Application (2017-2028)
    5.2 Global Angiogenesis Modulators Revenue by Application
        5.2.1 Global Angiogenesis Modulators Historical Revenue by Application (2017-2022)
        5.2.2 Global Angiogenesis Modulators Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Angiogenesis Modulators Revenue Market Share by Application (2017-2028)
    5.3 Global Angiogenesis Modulators Price by Application
        5.3.1 Global Angiogenesis Modulators Price by Application (2017-2022)
        5.3.2 Global Angiogenesis Modulators Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Angiogenesis Modulators Market Size by Type
        6.1.1 North America Angiogenesis Modulators Sales by Type (2017-2028)
        6.1.2 North America Angiogenesis Modulators Revenue by Type (2017-2028)
    6.2 North America Angiogenesis Modulators Market Size by Application
        6.2.1 North America Angiogenesis Modulators Sales by Application (2017-2028)
        6.2.2 North America Angiogenesis Modulators Revenue by Application (2017-2028)
    6.3 North America Angiogenesis Modulators Market Size by Country
        6.3.1 North America Angiogenesis Modulators Sales by Country (2017-2028)
        6.3.2 North America Angiogenesis Modulators Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Angiogenesis Modulators Market Size by Type
        7.1.1 Europe Angiogenesis Modulators Sales by Type (2017-2028)
        7.1.2 Europe Angiogenesis Modulators Revenue by Type (2017-2028)
    7.2 Europe Angiogenesis Modulators Market Size by Application
        7.2.1 Europe Angiogenesis Modulators Sales by Application (2017-2028)
        7.2.2 Europe Angiogenesis Modulators Revenue by Application (2017-2028)
    7.3 Europe Angiogenesis Modulators Market Size by Country
        7.3.1 Europe Angiogenesis Modulators Sales by Country (2017-2028)
        7.3.2 Europe Angiogenesis Modulators Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Angiogenesis Modulators Market Size by Type
        8.1.1 Asia Pacific Angiogenesis Modulators Sales by Type (2017-2028)
        8.1.2 Asia Pacific Angiogenesis Modulators Revenue by Type (2017-2028)
    8.2 Asia Pacific Angiogenesis Modulators Market Size by Application
        8.2.1 Asia Pacific Angiogenesis Modulators Sales by Application (2017-2028)
        8.2.2 Asia Pacific Angiogenesis Modulators Revenue by Application (2017-2028)
    8.3 Asia Pacific Angiogenesis Modulators Market Size by Region
        8.3.1 Asia Pacific Angiogenesis Modulators Sales by Region (2017-2028)
        8.3.2 Asia Pacific Angiogenesis Modulators Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Angiogenesis Modulators Market Size by Type
        9.1.1 Latin America Angiogenesis Modulators Sales by Type (2017-2028)
        9.1.2 Latin America Angiogenesis Modulators Revenue by Type (2017-2028)
    9.2 Latin America Angiogenesis Modulators Market Size by Application
        9.2.1 Latin America Angiogenesis Modulators Sales by Application (2017-2028)
        9.2.2 Latin America Angiogenesis Modulators Revenue by Application (2017-2028)
    9.3 Latin America Angiogenesis Modulators Market Size by Country
        9.3.1 Latin America Angiogenesis Modulators Sales by Country (2017-2028)
        9.3.2 Latin America Angiogenesis Modulators Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Angiogenesis Modulators Market Size by Type
        10.1.1 Middle East and Africa Angiogenesis Modulators Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Angiogenesis Modulators Revenue by Type (2017-2028)
    10.2 Middle East and Africa Angiogenesis Modulators Market Size by Application
        10.2.1 Middle East and Africa Angiogenesis Modulators Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Angiogenesis Modulators Revenue by Application (2017-2028)
    10.3 Middle East and Africa Angiogenesis Modulators Market Size by Country
        10.3.1 Middle East and Africa Angiogenesis Modulators Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Angiogenesis Modulators Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Celgene Corporation (USA)
        11.1.1 Celgene Corporation (USA) Corporation Information
        11.1.2 Celgene Corporation (USA) Overview
        11.1.3 Celgene Corporation (USA) Angiogenesis Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Celgene Corporation (USA) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Celgene Corporation (USA) Recent Developments
    11.2 Eisai (Japan)
        11.2.1 Eisai (Japan) Corporation Information
        11.2.2 Eisai (Japan) Overview
        11.2.3 Eisai (Japan) Angiogenesis Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Eisai (Japan) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Eisai (Japan) Recent Developments
    11.3 Amgen, Inc. (USA)
        11.3.1 Amgen, Inc. (USA) Corporation Information
        11.3.2 Amgen, Inc. (USA) Overview
        11.3.3 Amgen, Inc. (USA) Angiogenesis Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Amgen, Inc. (USA) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Amgen, Inc. (USA) Recent Developments
    11.4 Genentech, Inc. (USA)
        11.4.1 Genentech, Inc. (USA) Corporation Information
        11.4.2 Genentech, Inc. (USA) Overview
        11.4.3 Genentech, Inc. (USA) Angiogenesis Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Genentech, Inc. (USA) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Genentech, Inc. (USA) Recent Developments
    11.5 GlaxoSmithKline plc (UK)
        11.5.1 GlaxoSmithKline plc (UK) Corporation Information
        11.5.2 GlaxoSmithKline plc (UK) Overview
        11.5.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 GlaxoSmithKline plc (UK) Recent Developments
    11.6 Bayer Pharma AG (Germany)
        11.6.1 Bayer Pharma AG (Germany) Corporation Information
        11.6.2 Bayer Pharma AG (Germany) Overview
        11.6.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Bayer Pharma AG (Germany) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Bayer Pharma AG (Germany) Recent Developments
    11.7 Bionomics Ltd. (Australia)
        11.7.1 Bionomics Ltd. (Australia) Corporation Information
        11.7.2 Bionomics Ltd. (Australia) Overview
        11.7.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Bionomics Ltd. (Australia) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Bionomics Ltd. (Australia) Recent Developments
    11.8 CASI Pharmaceuticals, Inc. (USA)
        11.8.1 CASI Pharmaceuticals, Inc. (USA) Corporation Information
        11.8.2 CASI Pharmaceuticals, Inc. (USA) Overview
        11.8.3 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 CASI Pharmaceuticals, Inc. (USA) Recent Developments
    11.9 AstraZeneca plc (UK)
        11.9.1 AstraZeneca plc (UK) Corporation Information
        11.9.2 AstraZeneca plc (UK) Overview
        11.9.3 AstraZeneca plc (UK) Angiogenesis Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 AstraZeneca plc (UK) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 AstraZeneca plc (UK) Recent Developments
    11.10 Eli Lilly and Company (USA)
        11.10.1 Eli Lilly and Company (USA) Corporation Information
        11.10.2 Eli Lilly and Company (USA) Overview
        11.10.3 Eli Lilly and Company (USA) Angiogenesis Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Eli Lilly and Company (USA) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Eli Lilly and Company (USA) Recent Developments
    11.11 F.Hoffmann-La Roche AG (Switzerland)
        11.11.1 F.Hoffmann-La Roche AG (Switzerland) Corporation Information
        11.11.2 F.Hoffmann-La Roche AG (Switzerland) Overview
        11.11.3 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 F.Hoffmann-La Roche AG (Switzerland) Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Angiogenesis Modulators Industry Chain Analysis
    12.2 Angiogenesis Modulators Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Angiogenesis Modulators Production Mode & Process
    12.4 Angiogenesis Modulators Sales and Marketing
        12.4.1 Angiogenesis Modulators Sales Channels
        12.4.2 Angiogenesis Modulators Distributors
    12.5 Angiogenesis Modulators Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Angiogenesis Modulators Industry Trends
    13.2 Angiogenesis Modulators Market Drivers
    13.3 Angiogenesis Modulators Market Challenges
    13.4 Angiogenesis Modulators Market Restraints
14 Key Findings in The Global Angiogenesis Modulators Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Angiogenesis Modulators Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Angiogenesis Inhibitors
    Table 3. Major Manufacturers of Angiogenesis Stimulators
    Table 4. Major Manufacturers of Angiogenin
    Table 5. Major Manufacturers of Others
    Table 6. Global Angiogenesis Modulators Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Angiogenesis Modulators Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Angiogenesis Modulators Sales by Region (2017-2022) & (K MT)
    Table 9. Global Angiogenesis Modulators Sales Market Share by Region (2017-2022)
    Table 10. Global Angiogenesis Modulators Sales by Region (2023-2028) & (K MT)
    Table 11. Global Angiogenesis Modulators Sales Market Share by Region (2023-2028)
    Table 12. Global Angiogenesis Modulators Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Angiogenesis Modulators Revenue Market Share by Region (2017-2022)
    Table 14. Global Angiogenesis Modulators Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Angiogenesis Modulators Revenue Market Share by Region (2023-2028)
    Table 16. Global Angiogenesis Modulators Sales by Manufacturers (2017-2022) & (K MT)
    Table 17. Global Angiogenesis Modulators Sales Share by Manufacturers (2017-2022)
    Table 18. Global Angiogenesis Modulators Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Angiogenesis Modulators Revenue Share by Manufacturers (2017-2022)
    Table 20. Angiogenesis Modulators Price by Manufacturers (2017-2022) &(USD/MT)
    Table 21. Global Angiogenesis Modulators Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Angiogenesis Modulators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiogenesis Modulators as of 2021)
    Table 23. Angiogenesis Modulators Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Angiogenesis Modulators Product Offered
    Table 25. Date of Manufacturers Enter into Angiogenesis Modulators Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
    Table 28. Global Angiogenesis Modulators Sales by Type (2023-2028) & (K MT)
    Table 29. Global Angiogenesis Modulators Sales Share by Type (2017-2022)
    Table 30. Global Angiogenesis Modulators Sales Share by Type (2023-2028)
    Table 31. Global Angiogenesis Modulators Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Angiogenesis Modulators Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Angiogenesis Modulators Revenue Share by Type (2017-2022)
    Table 34. Global Angiogenesis Modulators Revenue Share by Type (2023-2028)
    Table 35. Angiogenesis Modulators Price by Type (2017-2022) & (USD/MT)
    Table 36. Global Angiogenesis Modulators Price Forecast by Type (2023-2028) & (USD/MT)
    Table 37. Global Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
    Table 38. Global Angiogenesis Modulators Sales by Application (2023-2028) & (K MT)
    Table 39. Global Angiogenesis Modulators Sales Share by Application (2017-2022)
    Table 40. Global Angiogenesis Modulators Sales Share by Application (2023-2028)
    Table 41. Global Angiogenesis Modulators Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Angiogenesis Modulators Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Angiogenesis Modulators Revenue Share by Application (2017-2022)
    Table 44. Global Angiogenesis Modulators Revenue Share by Application (2023-2028)
    Table 45. Angiogenesis Modulators Price by Application (2017-2022) & (USD/MT)
    Table 46. Global Angiogenesis Modulators Price Forecast by Application (2023-2028) & (USD/MT)
    Table 47. North America Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
    Table 48. North America Angiogenesis Modulators Sales by Type (2023-2028) & (K MT)
    Table 49. North America Angiogenesis Modulators Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Angiogenesis Modulators Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
    Table 52. North America Angiogenesis Modulators Sales by Application (2023-2028) & (K MT)
    Table 53. North America Angiogenesis Modulators Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Angiogenesis Modulators Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Angiogenesis Modulators Sales by Country (2017-2022) & (K MT)
    Table 56. North America Angiogenesis Modulators Sales by Country (2023-2028) & (K MT)
    Table 57. North America Angiogenesis Modulators Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Angiogenesis Modulators Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
    Table 60. Europe Angiogenesis Modulators Sales by Type (2023-2028) & (K MT)
    Table 61. Europe Angiogenesis Modulators Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Angiogenesis Modulators Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
    Table 64. Europe Angiogenesis Modulators Sales by Application (2023-2028) & (K MT)
    Table 65. Europe Angiogenesis Modulators Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Angiogenesis Modulators Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Angiogenesis Modulators Sales by Country (2017-2022) & (K MT)
    Table 68. Europe Angiogenesis Modulators Sales by Country (2023-2028) & (K MT)
    Table 69. Europe Angiogenesis Modulators Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Angiogenesis Modulators Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
    Table 72. Asia Pacific Angiogenesis Modulators Sales by Type (2023-2028) & (K MT)
    Table 73. Asia Pacific Angiogenesis Modulators Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Angiogenesis Modulators Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
    Table 76. Asia Pacific Angiogenesis Modulators Sales by Application (2023-2028) & (K MT)
    Table 77. Asia Pacific Angiogenesis Modulators Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Angiogenesis Modulators Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Angiogenesis Modulators Sales by Region (2017-2022) & (K MT)
    Table 80. Asia Pacific Angiogenesis Modulators Sales by Region (2023-2028) & (K MT)
    Table 81. Asia Pacific Angiogenesis Modulators Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Angiogenesis Modulators Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
    Table 84. Latin America Angiogenesis Modulators Sales by Type (2023-2028) & (K MT)
    Table 85. Latin America Angiogenesis Modulators Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Angiogenesis Modulators Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
    Table 88. Latin America Angiogenesis Modulators Sales by Application (2023-2028) & (K MT)
    Table 89. Latin America Angiogenesis Modulators Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Angiogenesis Modulators Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Angiogenesis Modulators Sales by Country (2017-2022) & (K MT)
    Table 92. Latin America Angiogenesis Modulators Sales by Country (2023-2028) & (K MT)
    Table 93. Latin America Angiogenesis Modulators Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Angiogenesis Modulators Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Angiogenesis Modulators Sales by Type (2017-2022) & (K MT)
    Table 96. Middle East and Africa Angiogenesis Modulators Sales by Type (2023-2028) & (K MT)
    Table 97. Middle East and Africa Angiogenesis Modulators Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Angiogenesis Modulators Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Angiogenesis Modulators Sales by Application (2017-2022) & (K MT)
    Table 100. Middle East and Africa Angiogenesis Modulators Sales by Application (2023-2028) & (K MT)
    Table 101. Middle East and Africa Angiogenesis Modulators Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Angiogenesis Modulators Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Angiogenesis Modulators Sales by Country (2017-2022) & (K MT)
    Table 104. Middle East and Africa Angiogenesis Modulators Sales by Country (2023-2028) & (K MT)
    Table 105. Middle East and Africa Angiogenesis Modulators Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Angiogenesis Modulators Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Celgene Corporation (USA) Corporation Information
    Table 108. Celgene Corporation (USA) Description and Major Businesses
    Table 109. Celgene Corporation (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 110. Celgene Corporation (USA) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Celgene Corporation (USA) Recent Developments
    Table 112. Eisai (Japan) Corporation Information
    Table 113. Eisai (Japan) Description and Major Businesses
    Table 114. Eisai (Japan) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. Eisai (Japan) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Eisai (Japan) Recent Developments
    Table 117. Amgen, Inc. (USA) Corporation Information
    Table 118. Amgen, Inc. (USA) Description and Major Businesses
    Table 119. Amgen, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 120. Amgen, Inc. (USA) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Amgen, Inc. (USA) Recent Developments
    Table 122. Genentech, Inc. (USA) Corporation Information
    Table 123. Genentech, Inc. (USA) Description and Major Businesses
    Table 124. Genentech, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 125. Genentech, Inc. (USA) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Genentech, Inc. (USA) Recent Developments
    Table 127. GlaxoSmithKline plc (UK) Corporation Information
    Table 128. GlaxoSmithKline plc (UK) Description and Major Businesses
    Table 129. GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 130. GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. GlaxoSmithKline plc (UK) Recent Developments
    Table 132. Bayer Pharma AG (Germany) Corporation Information
    Table 133. Bayer Pharma AG (Germany) Description and Major Businesses
    Table 134. Bayer Pharma AG (Germany) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 135. Bayer Pharma AG (Germany) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Bayer Pharma AG (Germany) Recent Developments
    Table 137. Bionomics Ltd. (Australia) Corporation Information
    Table 138. Bionomics Ltd. (Australia) Description and Major Businesses
    Table 139. Bionomics Ltd. (Australia) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 140. Bionomics Ltd. (Australia) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Bionomics Ltd. (Australia) Recent Developments
    Table 142. CASI Pharmaceuticals, Inc. (USA) Corporation Information
    Table 143. CASI Pharmaceuticals, Inc. (USA) Description and Major Businesses
    Table 144. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 145. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. CASI Pharmaceuticals, Inc. (USA) Recent Developments
    Table 147. AstraZeneca plc (UK) Corporation Information
    Table 148. AstraZeneca plc (UK) Description and Major Businesses
    Table 149. AstraZeneca plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 150. AstraZeneca plc (UK) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. AstraZeneca plc (UK) Recent Developments
    Table 152. Eli Lilly and Company (USA) Corporation Information
    Table 153. Eli Lilly and Company (USA) Description and Major Businesses
    Table 154. Eli Lilly and Company (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 155. Eli Lilly and Company (USA) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Eli Lilly and Company (USA) Recent Developments
    Table 157. F.Hoffmann-La Roche AG (Switzerland) Corporation Information
    Table 158. F.Hoffmann-La Roche AG (Switzerland) Description and Major Businesses
    Table 159. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 160. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. F.Hoffmann-La Roche AG (Switzerland) Recent Developments
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Angiogenesis Modulators Distributors List
    Table 165. Angiogenesis Modulators Customers List
    Table 166. Angiogenesis Modulators Market Trends
    Table 167. Angiogenesis Modulators Market Drivers
    Table 168. Angiogenesis Modulators Market Challenges
    Table 169. Angiogenesis Modulators Market Restraints
    Table 170. Research Programs/Design for This Report
    Table 171. Key Data Information from Secondary Sources
    Table 172. Key Data Information from Primary Sources
List of Figures
    Figure 1. Angiogenesis Modulators Product Picture
    Figure 3. Global Angiogenesis Modulators Market Share by Type in 2021 & 2028
    Figure 3. Angiogenesis Inhibitors Product Picture
    Figure 4. Angiogenesis Stimulators Product Picture
    Figure 5. Angiogenin Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Angiogenesis Modulators Market Share by Application in 2021 & 2028
    Figure 8. Breast Cancer
    Figure 9. Colorectal Cancer
    Figure 10. Lung Cancer
    Figure 11. Prostate Cancer
    Figure 12. Others
    Figure 13. Angiogenesis Modulators Report Years Considered
    Figure 14. Global Angiogenesis Modulators Sales 2017-2028 (K MT)
    Figure 15. Global Angiogenesis Modulators Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Angiogenesis Modulators Revenue 2017-2028 (US$ Million)
    Figure 17. Global Angiogenesis Modulators Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Angiogenesis Modulators Sales Market Share by Region (2017-2022)
    Figure 19. Global Angiogenesis Modulators Sales Market Share by Region (2023-2028)
    Figure 20. North America Angiogenesis Modulators Sales YoY (2017-2028) & (K MT)
    Figure 21. North America Angiogenesis Modulators Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Angiogenesis Modulators Sales YoY (2017-2028) & (K MT)
    Figure 23. Europe Angiogenesis Modulators Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Angiogenesis Modulators Sales YoY (2017-2028) & (K MT)
    Figure 25. Asia-Pacific Angiogenesis Modulators Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Angiogenesis Modulators Sales YoY (2017-2028) & (K MT)
    Figure 27. Latin America Angiogenesis Modulators Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Angiogenesis Modulators Sales YoY (2017-2028) & (K MT)
    Figure 29. Middle East & Africa Angiogenesis Modulators Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Angiogenesis Modulators Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Angiogenesis Modulators in the World: Market Share by Angiogenesis Modulators Revenue in 2021
    Figure 32. Global Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Angiogenesis Modulators Sales Market Share by Type (2017-2028)
    Figure 34. Global Angiogenesis Modulators Revenue Market Share by Type (2017-2028)
    Figure 35. Global Angiogenesis Modulators Sales Market Share by Application (2017-2028)
    Figure 36. Global Angiogenesis Modulators Revenue Market Share by Application (2017-2028)
    Figure 37. North America Angiogenesis Modulators Sales Market Share by Type (2017-2028)
    Figure 38. North America Angiogenesis Modulators Revenue Market Share by Type (2017-2028)
    Figure 39. North America Angiogenesis Modulators Sales Market Share by Application (2017-2028)
    Figure 40. North America Angiogenesis Modulators Revenue Market Share by Application (2017-2028)
    Figure 41. North America Angiogenesis Modulators Sales Share by Country (2017-2028)
    Figure 42. North America Angiogenesis Modulators Revenue Share by Country (2017-2028)
    Figure 43. U.S. Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Angiogenesis Modulators Sales Market Share by Type (2017-2028)
    Figure 46. Europe Angiogenesis Modulators Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Angiogenesis Modulators Sales Market Share by Application (2017-2028)
    Figure 48. Europe Angiogenesis Modulators Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Angiogenesis Modulators Sales Share by Country (2017-2028)
    Figure 50. Europe Angiogenesis Modulators Revenue Share by Country (2017-2028)
    Figure 51. Germany Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 52. France Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Angiogenesis Modulators Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Angiogenesis Modulators Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Angiogenesis Modulators Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Angiogenesis Modulators Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Angiogenesis Modulators Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Angiogenesis Modulators Revenue Share by Region (2017-2028)
    Figure 62. China Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 65. India Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Angiogenesis Modulators Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Angiogenesis Modulators Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Angiogenesis Modulators Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Angiogenesis Modulators Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Angiogenesis Modulators Sales Share by Country (2017-2028)
    Figure 77. Latin America Angiogenesis Modulators Revenue Share by Country (2017-2028)
    Figure 78. Mexico Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Angiogenesis Modulators Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Angiogenesis Modulators Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Angiogenesis Modulators Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Angiogenesis Modulators Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Angiogenesis Modulators Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Angiogenesis Modulators Revenue Share by Country (2017-2028)
    Figure 87. Turkey Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 89. UAE Angiogenesis Modulators Revenue (2017-2028) & (US$ Million)
    Figure 90. Angiogenesis Modulators Value Chain
    Figure 91. Angiogenesis Modulators Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Celgene Corporation (USA)
Eisai (Japan)
Amgen, Inc. (USA)
Genentech, Inc. (USA)
GlaxoSmithKline plc (UK)
Bayer Pharma AG (Germany)
Bionomics Ltd. (Australia)
CASI Pharmaceuticals, Inc. (USA)
AstraZeneca plc (UK)
Eli Lilly and Company (USA)
F.Hoffmann-La Roche AG (Switzerland)
Frequently Asked Questions
Angiogenesis Modulators report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Angiogenesis Modulators report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Angiogenesis Modulators report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Yachts Charter

Yachts Charter market is segmented by players, region (country), by Type and by Application. Play ... Read More

Orthopedic Plates

Orthopedic Plates market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More